vs
HARTE HANKS INC（HHS）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是HARTE HANKS INC的1.9倍（$75.5M vs $39.9M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -15.4%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-686.0K），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -6.4%）
哈特·汉克斯是一家总部位于美国马萨诸塞州波士顿的全球营销服务企业，主营业务涵盖数据分析、营销战略规划、营销技术支持、创意服务、数字营销、客户服务、直邮服务以及物流履约等多个领域，为全球客户提供全方位的营销解决方案。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
HHS vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.9倍
$39.9M
营收增速更快
PBYI
高出43.1%
-15.4%
自由现金流更多
PBYI
多$15.1M
$-686.0K
两年增速更快
PBYI
近两年复合增速
-6.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $39.9M | $75.5M |
| 净利润 | $2.2M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | -0.3% | 22.7% |
| 净利率 | 5.5% | — |
| 营收同比 | -15.4% | 27.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.30 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HHSPBYI
| Q4 25 | $39.9M | $75.5M | ||
| Q3 25 | $39.5M | $54.5M | ||
| Q2 25 | $38.6M | $52.4M | ||
| Q1 25 | $41.6M | $46.0M | ||
| Q4 24 | $47.1M | $59.1M | ||
| Q3 24 | $47.6M | $80.5M | ||
| Q2 24 | $45.0M | $47.1M | ||
| Q1 24 | $45.4M | $43.8M |
净利润HHSPBYI
| Q4 25 | $2.2M | — | ||
| Q3 25 | $-2.3M | $8.8M | ||
| Q2 25 | $-335.0K | $5.9M | ||
| Q1 25 | $-392.0K | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $142.0K | $20.3M | ||
| Q2 24 | $-27.8M | $-4.5M | ||
| Q1 24 | $-171.0K | $-4.8M |
毛利率HHSPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率HHSPBYI
| Q4 25 | -0.3% | 22.7% | ||
| Q3 25 | 1.3% | 17.6% | ||
| Q2 25 | 0.1% | 12.7% | ||
| Q1 25 | -0.1% | 8.7% | ||
| Q4 24 | -3.3% | 22.6% | ||
| Q3 24 | 4.0% | 27.4% | ||
| Q2 24 | 3.0% | -4.6% | ||
| Q1 24 | 0.8% | -5.3% |
净利率HHSPBYI
| Q4 25 | 5.5% | — | ||
| Q3 25 | -5.8% | 16.2% | ||
| Q2 25 | -0.9% | 11.2% | ||
| Q1 25 | -0.9% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.3% | 25.2% | ||
| Q2 24 | -61.8% | -9.6% | ||
| Q1 24 | -0.4% | -11.0% |
每股收益（稀释后）HHSPBYI
| Q4 25 | $0.30 | $0.26 | ||
| Q3 25 | $-0.31 | $0.17 | ||
| Q2 25 | $-0.05 | $0.12 | ||
| Q1 25 | $-0.05 | $0.06 | ||
| Q4 24 | $-0.31 | $0.40 | ||
| Q3 24 | $0.02 | $0.41 | ||
| Q2 24 | $-3.84 | $-0.09 | ||
| Q1 24 | $-0.02 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.6M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $20.5M | $130.3M |
| 总资产 | $91.8M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资HHSPBYI
| Q4 25 | $5.6M | $97.5M | ||
| Q3 25 | $6.5M | $94.4M | ||
| Q2 25 | $4.8M | $96.0M | ||
| Q1 25 | $9.0M | $93.2M | ||
| Q4 24 | $9.8M | $101.0M | ||
| Q3 24 | $5.9M | $96.7M | ||
| Q2 24 | $11.0M | $96.8M | ||
| Q1 24 | $11.5M | $107.2M |
总债务HHSPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益HHSPBYI
| Q4 25 | $20.5M | $130.3M | ||
| Q3 25 | $19.9M | $115.3M | ||
| Q2 25 | $22.2M | $104.7M | ||
| Q1 25 | $21.4M | $97.1M | ||
| Q4 24 | $21.7M | $92.1M | ||
| Q3 24 | $21.0M | $71.1M | ||
| Q2 24 | $20.6M | $48.5M | ||
| Q1 24 | $20.0M | $51.0M |
总资产HHSPBYI
| Q4 25 | $91.8M | $216.3M | ||
| Q3 25 | $92.7M | $202.9M | ||
| Q2 25 | $95.0M | $194.9M | ||
| Q1 25 | $100.6M | $196.2M | ||
| Q4 24 | $101.8M | $213.3M | ||
| Q3 24 | $108.1M | $220.7M | ||
| Q2 24 | $109.7M | $205.0M | ||
| Q1 24 | $113.4M | $214.1M |
负债/权益比HHSPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $737.0K | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-686.0K | $14.4M |
| 自由现金流率自由现金流/营收 | -1.7% | 19.1% |
| 资本支出强度资本支出/营收 | 3.6% | 0.0% |
| 现金转化率经营现金流/净利润 | 0.33× | — |
| 过去12个月自由现金流最近4个季度 | $-4.5M | $41.7M |
8季度趋势，按日历期对齐
经营现金流HHSPBYI
| Q4 25 | $737.0K | $14.4M | ||
| Q3 25 | $3.2M | $9.7M | ||
| Q2 25 | $-4.8M | $14.1M | ||
| Q1 25 | $-818.0K | $3.6M | ||
| Q4 24 | $4.0M | $15.6M | ||
| Q3 24 | $-2.9M | $11.0M | ||
| Q2 24 | $1.6M | $1.0M | ||
| Q1 24 | $-5.7M | $11.2M |
自由现金流HHSPBYI
| Q4 25 | $-686.0K | $14.4M | ||
| Q3 25 | $2.2M | $9.7M | ||
| Q2 25 | $-5.1M | $14.1M | ||
| Q1 25 | $-923.0K | $3.6M | ||
| Q4 24 | $3.4M | $15.6M | ||
| Q3 24 | $-4.9M | $11.0M | ||
| Q2 24 | $926.0K | $1.0M | ||
| Q1 24 | $-6.2M | — |
自由现金流率HHSPBYI
| Q4 25 | -1.7% | 19.1% | ||
| Q3 25 | 5.5% | 17.7% | ||
| Q2 25 | -13.1% | 26.8% | ||
| Q1 25 | -2.2% | 7.7% | ||
| Q4 24 | 7.3% | 26.4% | ||
| Q3 24 | -10.2% | 13.7% | ||
| Q2 24 | 2.1% | 2.1% | ||
| Q1 24 | -13.7% | — |
资本支出强度HHSPBYI
| Q4 25 | 3.6% | 0.0% | ||
| Q3 25 | 2.5% | 0.0% | ||
| Q2 25 | 0.6% | 0.0% | ||
| Q1 25 | 0.3% | 0.1% | ||
| Q4 24 | 1.3% | 0.0% | ||
| Q3 24 | 4.0% | 0.0% | ||
| Q2 24 | 1.5% | 0.0% | ||
| Q1 24 | 1.2% | 0.0% |
现金转化率HHSPBYI
| Q4 25 | 0.33× | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | -20.76× | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HHS
| Fulfillment And Logistics Services | $17.3M | 43% |
| Customer Care | $13.7M | 34% |
| Other | $8.9M | 22% |
PBYI
暂无分部数据
